Fundraising FoxAberdare Ventures
Venture capitalSan Francisco · Seed–Series A · 1 people tracked
Also known as ABERDARE MANAGEMENT COMPANY, LLC
Find your way into Aberdare Ventures
4 people in our graph share verified history with the Aberdare Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Aberdare Ventures is a venture capital firm based in Menlo Park, California. It invests exclusively in companies working to make healthcare more efficient, lower cost, and smarter.
Source: firm website, verified Sep 22, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 8 of 11 portfolio companiesHealthtech ×7Digital Health ×6AI & Machine Learning ×3Biotech ×2Medical Devices ×2Data & Infrastructure ×1Mental Health ×1Wellness & Fitness ×1
HQs:United States×8
Investments · 11 tracked
founders shown can be your intro pathBy year:2018 · 12015 · 12014 · 12012 · 12007 · 12006 · 12002 · 17 dated
Cyclerion is a biopharmaceutical company developing therapeutics for neuropsychiatric diseases, with a lead candidate (CYC-126) for treatment-resistant depression that pairs anesthetic agents with a personalized biofeedback-driven device.
BiotechDigital HealthMental HealthCambridge, US
William Huyett(Executive Officer)Mark G. Currie(Executive Officer)inRegina M. Graul(President and Chief Executive Officer)inOle Isacson(Director)Stephanie Lovell(Director)Marsha Fanucci(Director)
Co-investorsPappas CapitalEcoR1 CapitalInvusPolaris Partners
Cricket Health provides value-based kidney care, using a holistic approach to treat people with chronic kidney disease and related cardiovascular conditions.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Arvind Rajan(Executive Officer, Director)inDr. Carney Taylor(Chief Medical Officer)Dr. Terry Ketchersid(Senior Vice President, Medical Office)Dr. Julie Dominguez(Vice President, Medical Office)
BoardVincent Kim(Director)
Co-investorsLifeforce CapitalNext Play VenturesNFXFirst Round CapitaliSeed VenturesLiquid Ventures+3 more
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesMitsui Global InvestmentOUP (Osage University Partners)Windham Capital PartnersNorth Bridge Venture Partners
Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesRedwood City, US
Co-investorsBay City CapitalNew Enterprise Associates (NEA)Accuitive Medical Ventures
BrainHQ is an online brain-training program built on neuroplasticity research, offering adaptive exercises that target attention, brain speed, memory, people skills, navigation, and intelligence.
Digital HealthHealthtechWellness & Fitness
Michael Merzenich(Lead Neuroscientist)
RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechPortland, US
Josh Benner(Co-Founder & CEO)inLisa Jurinka(SVP, General Counsel)inNiteesh Choudhry(SVP, Chief Medical and Science Officer)inAmie Joyce(SVP, Head of Technology Operations)inPatrick Baker(SVP, General Manager at Mosaic Pharmacy Service)Jessica Frank(SVP, Client Success)in
Co-investorsPrimus Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Autonomic TechnologiesAnacor PharmaceuticalCervel NeurotechConatus PharmaceuticalsSonitus Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitionsCyclerion TherapeuticsNASDAQ: CYCNMC10acq. by Medidata
Portfolio news
latest coverage across their companiesCyclerion Therapeutics · thestockobserver.com · Sep 3, 2026
RxAnte · nasdaqprivatemarket.com · Apr 3, 2026
Fund performance · per public LP disclosures · 2
as of Sep 2021| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Aberdare Ventures IV, LPLPs: California Public Employees' Retirement System | 2008 | — | -0.2% | 0.99x | 0.46x |
| Aberdare Ventures III, LPLPs: California Public Employees' Retirement System | 2005 | — | 2.7% | 1.17x | 0.98x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Jul 2013
Disclosed stake · filed Apr 2012
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Aberdare Ventures made?
- Aberdare Ventures has 11 tracked investments, 2 of which have exited.
- What stage does Aberdare Ventures invest at?
- Aberdare Ventures invests at the Seed, Series A stages.
- What is Aberdare Ventures's typical check size?
- Aberdare Ventures typically writes checks of $500K – $15M.
- What sectors does Aberdare Ventures focus on?
- Aberdare Ventures focuses on Healthtech.
- Where is Aberdare Ventures located?
- Aberdare Ventures is headquartered in San Francisco, US.
- Does Aberdare Ventures lead rounds?
- Aberdare Ventures typically participates in rounds rather than leading them.
Images
Co-investors · 7
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Breakthrough Energy, founded by Bill Gates, backs innovators developing affordable, reliable, and clean energy technologies, investing across manufacturing, electricity, agriculture, transportation, and buildings.
MassMutual Ventures is the venture capital arm of Massachusetts Mutual Life Insurance Company, investing in technology companies and supporting their growth with capital, connections, and expertise.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Advent Life Sciences is a trans-Atlantic venture capital firm investing in early and mid-stage life sciences companies across the UK, Europe and the USA.
Acorn Bioventures invests across multiple stages in small-cap public and private biotechnology companies developing novel innovative medicines. The firm offers flexible capital structures including seed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, and open market purchases.
Firms observed investing alongside Aberdare Ventures, from public investor directories. Shared companies are the overlap with Aberdare Ventures's recorded portfolio.
Similar investors
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.